Skip to main content
Trending
Nordic defenseChildhood obesityMonetary policyTax strategyCollege affordabilityFood chemistryDomestic deploymentBundesliga historyDrug discoverySearch algorithmsCivic lotteriesCarbon marketsStellar physicsSteamos expansionGrid expansionTranslated fictionDeli supply chainThermal managementHappiness psychologyLabor economicsCivil procedureBuilding scienceDietary restraintManga publishingValuation standardsStatistical modelingRemote work dynamicsFoldable hardwareHealth benefitsEu governance

Health

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Food Safety

Massive Cyclospora Outbreak Prompts Lettuce Warnings and Precautionary Menu Changes

7 sources · 55d ago

Dementia Prevention

Major $100M Trial Tests GLP-1 Drugs and Lifestyle Changes to Prevent Dementia

2 sources · 55d ago

Deep Dive

The Evidence Pack: The Clinical Reality of NAD+ Precursors for Human Longevity

6 sources · 55d ago

More in Health

ExplainerPrecision Oncology

FDA Approves First Solid Tumor Therapy Requiring Circulating Tumor DNA Test for Adjuvant Treatment Selection

Precision Oncologists 40%Patient Advocacy Groups 35%Health Economists & Access Advocates 25%

7 sources · 55d ago

Sleep ApneaExplainer

FDA Accepts NDA for AD109, Potential First Oral Drug to Treat Neuromuscular Cause of Sleep Apnea

Clinical Researchers 40%Industry Analysts 30%Patient Care Advocates 30%

3 sources · 55d ago

ExplainerAortic Stenosis

Landmark 7-Year Trial Finds Non-Surgical Heart Valve Replacement Matches Open-Heart Surgery Durability

Interventional Cardiologists 40%Cardiac Surgeons 35%Evidence Synthesis 25%

4 sources · 55d ago

ExplainerDigital Therapeutics

FDA Grants Breakthrough Status to Video Game Treatment for Pediatric ADHD

Clinical Researchers 35%Digital Health Advocates 35%Regulatory Experts 30%

7 sources · 55d ago

Tourette SyndromeClinical Trial

First Drug Designed for Pediatric Tics Halves Relapse Risk in Phase 3 Tourette Syndrome Trial

Pediatric Neurologists 45%Patient Advocates & Families 35%Clinical Researchers 20%

5 sources · 55d ago

Bone HealthClinical Evidence

Real-World Data Shows Semaglutide Lowers Fracture Risk by 15% in Diabetics, Defying Weight Loss Expectations

Clinical Endocrinologists 40%Bone Health Researchers 35%Real-World Data Analysts 25%

2 sources · 56d ago

ExplainerLongevity Regulation

FDA and CMS Open Historic Dialogue on Regulating Aging as a Treatable Condition

Longevity Biotech Founders 40%Regulatory Pragmatists 35%Health Equity Advocates 25%

3 sources · 56d ago

ExplainerDementia Care

FDA Approves First Non-Antipsychotic Drug to Treat Agitation in Alzheimer's Disease

Geriatric Psychiatrists 35%Patient Advocates 35%Regulatory Watchdogs 30%

3 sources · 56d ago

Menopause CarePolicy Reversal

FDA Removes Decades-Old Black Box Warning from Menopausal Hormone Therapy

Women's Health Specialists 45%Oncology & Risk Experts 30%Federal Regulators 25%

4 sources · 56d ago

Blindspot

Important stories the mainstream barely covered

High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.

All blindspots →
news politics

House Passes Bill to Make Daylight Saving Time Permanent, Sending Measure to Senate

The U.S. House of Representatives voted 308-117 to pass the Sunshine Protection Act, advancing a bipartisan effort to end the twice-yearly clock changes. The legislation, backed by President Trump, now heads to the Senate where its future remains uncertain.

Permanent DST Advocates 45%Standard Time Proponents 35%Status Quo Defenders 20%

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy